XML 17 R7.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 1,702 $ 1,531
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 154 143
Deferred income taxes, net 129 (4)
Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gains/losses on other investments (8) (19)
Provisions for credit losses and legal and regulatory matters, net (3) 107
Share-based compensation expense 183 199
Unrealized gains on corporate-owned life insurance policies, net of expenses (152) (68)
Other 34 23
Net change in:    
Collateralized agreements, net of collateralized financings (750) (247)
Loans provided to financial advisors, net of repayments (471) (194)
Brokerage client receivables and other receivables, net (1,139) (170)
Trading instruments, net (21) 77
Derivative instruments, net 93 31
Other assets 68 78
Brokerage client payables and other payables 909 331
Accrued compensation, commissions and benefits (86) (109)
Proceeds from sales of securitizations and loans held for sale, net of purchases and originations of loans held for sale 201 (71)
Net cash provided by operating activities 843 1,638
Cash flows from investing activities:    
Increase in bank loans, net (5,509) (4,044)
Proceeds from sales of loans held for investment 615 218
Purchases of available-for-sale securities (947) (480)
Available-for-sale securities maturations, repayments and redemptions 1,324 1,531
Proceeds from sales of available-for-sale securities 40 78
Cash paid for acquisitions, net of cash acquired (484) 0
Additions to property and equipment (153) (144)
Sales of Federal Reserve Bank (“FRB”) and Federal Home Loan Bank (“FHLB”) stock 0 8
Equity method investments, net of distributions received (86) (24)
Other investing activities, net (94) (41)
Net cash used in investing activities (5,294) (2,898)
Cash flows from financing activities:    
Increase in bank deposits 4,422 1,239
Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements (1,319) (914)
Dividends on common and preferred stock (326) (314)
Employee stock purchases and exercise of stock options 33 26
Redemption of preferred stock (81) 0
Proceeds from FHLB advances 400 750
Repayments of FHLB advances (400) (950)
Proceeds from short-term borrowings 250 0
Other financing, net (11) (8)
Net cash provided by/(used in) financing activities 2,968 (171)
Currency adjustment:    
Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes (50) 48
Net decrease in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash (1,533) (1,383)
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year 14,787 14,348
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period 13,254 12,965
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash    
Cash and cash equivalents 9,977 9,195
Cash and cash equivalents segregated for regulatory purposes and restricted cash 3,277 3,770
Total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period 13,254 12,965
Supplemental disclosures of cash flow information:    
Cash paid for interest 1,259 1,394
Cash paid for income taxes, net 362 510
Cash outflows for lease liabilities 101 99
Non-cash right-of-use (“ROU”) assets recorded for new and modified leases 91 78
Non-cash acquisition-related contingent consideration $ 177 $ 0